Pronota

Ghent, Belgium Founded: 2004 • Age: 22 yrs Acquired By Biocartis
Diagnostics for heart failure, pre-eclampsia, and sepsis are provided.
Request Access

About Pronota

Pronota is a company based in Ghent (Belgium) founded in 2004 was acquired by Biocartis in September 2014.. Pronota has raised $34.75 million across 10 funding rounds from investors including Biocartis, Gimv and VIB. The company has 2 employees as of December 31, 2020. Pronota operates in a competitive market with competitors including SphingoTec, BG Medicine, Critical Diagnostics, Upstream Medical Technologies and Shape Medical Systems, among others.

  • Headquarter Ghent, Belgium
  • Employees 2 as on 31 Dec, 2020
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Mycartis Nv
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $34.75 M (USD)

    in 10 rounds

  • Latest Funding Round
    $1.8 M (USD), Series C

    Dec 12, 2012

  • Investors
    Biocartis

    & 9 more

  • Employee Count
    2

    as on Dec 31, 2020

  • Acquired by
    Biocartis

    (Sep 08, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Pronota

Pronota has successfully raised a total of $34.75M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $1.8 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series C — $1.8M
  • First Round

    (19 Apr 2006)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2012 Amount Series C - Pronota Valuation

investors

Jan, 2012 Amount Series C - Pronota Valuation Life Sciences Partners , Gimv
May, 2010 Amount Series B - Pronota Valuation MSC
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Pronota

Pronota has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Biocartis, Gimv and VIB. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments in life sciences businesses are managed.
Founded Year Domain Location
Private equity firm
Founded Year Domain Location
PE firm focusing on seed and early stage companies based out of Belgium
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Pronota

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Pronota

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pronota Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Pronota

Pronota operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SphingoTec, BG Medicine, Critical Diagnostics, Upstream Medical Technologies and Shape Medical Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed.
domain founded_year HQ Location
Diagnostic tests for cardiovascular disorders are developed and commercialized.
domain founded_year HQ Location
Biomarkers-based tests for cardiovascular disease diagnostics are developed.
domain founded_year HQ Location
Patented cardiac biomarkers are developed for heart disease diagnostics.
domain founded_year HQ Location
Cardiopulmonary exercise testing technology is developed for heart failure detection.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pronota

Frequently Asked Questions about Pronota

When was Pronota founded?

Pronota was founded in 2004 and raised its 1st funding round 2 years after it was founded.

Where is Pronota located?

Pronota is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.

Is Pronota a funded company?

Pronota is a funded company, having raised a total of $34.75M across 10 funding rounds to date. The company's 1st funding round was a Series B of $1.85M, raised on Apr 19, 2006.

How many employees does Pronota have?

As of Dec 31, 2020, the latest employee count at Pronota is 2.

What does Pronota do?

Pronota NV was founded in 2004 in Ghent, Belgium, within the medical diagnostics sector. Early detection of conditions including heart failure, pre-eclampsia, and sepsis is facilitated through proprietary, non-invasive tests. Biological samples proteomes are analyzed to develop a range of diagnostic products. Operations emphasize diagnosis and personalized healthcare, with services targeted at patient validation and portfolio expansion in Europe.

Who are the top competitors of Pronota?

Pronota's top competitors include SphingoTec, BG Medicine and Upstream Medical Technologies.

Who are Pronota's investors?

Pronota has 10 investors. Key investors include Biocartis, Gimv, VIB, Life Sciences Partners, and KBC Private Equity.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available